Metsera Reports Positive Phase 2b Results for First- and Best-in-Class Ultra-long Acting GLP-1 RA Candidate MET-097i, Enabling Rapid Transition into Phase 3

Placebo-subtracted mean weight loss up to 14.1%after 28 weeks with no plateauPotential for best-in-class tolerability with minimal diarrhea ...
The Malaysian Reserve

Lilly’s Kisunla (donanemab) receives marketing authorization by European Commission for the treatment of early symptomatic Alzheimer’s disease

Approved for earliest symptomatic stages of disease, demonstrating significant slowing of cognitive and functional decline Only therapy with evidence to ...
YouTube on MSN

Hey Dad, how do you tap a keg? 🍺

In this fun and educational video, we dive into the essential step-by-step process of how to tap a keg. Perfect for beginners ...

MBX Biosciences, Inc. (MBX) Discusses On Topline Results From Avail Phase 2 Trial Transcript

Ladies and gentlemen, greetings, and welcome to MBX Biosciences Conference Call. Today's call is being recorded. [Operator Instructions] As a reminder, this conference is being recorded. It is now my ...

Is it worth getting a private ADHD assessment?

We explain how much a private ADHD assessment typically costs, what to watch out for, and whether you can take a private ...